Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$27.42 - $43.63 $86,071 - $136,954
3,139 Added 14.2%
25,250 $784,000
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $55,449 - $79,374
1,520 Added 7.38%
22,111 $908,000
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $227,432 - $377,863
-6,869 Reduced 25.01%
20,591 $895,000
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $427,848 - $564,397
8,545 Added 45.18%
27,460 $1.38 Million
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $115,597 - $164,299
-2,042 Reduced 9.74%
18,915 $1.19 Million
Q1 2021

May 17, 2021

BUY
$86.23 - $125.19 $1.81 Million - $2.62 Million
20,957 New
20,957 $1.95 Million
Q3 2020

Nov 16, 2020

SELL
$81.91 - $134.94 $374,902 - $617,620
-4,577 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $380 - $626
7 Added 0.15%
4,577 $362,000
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $16,134 - $22,484
-327 Reduced 6.68%
4,570 $264,000
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $7,835 - $9,036
-153 Reduced 3.03%
4,897 $264,000
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $205,030 - $288,860
5,050 New
5,050 $264,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $261,294 - $344,008
-4,697 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $244,478 - $312,397
4,697 New
4,697 $309,000
Q2 2018

Aug 14, 2018

SELL
$48.33 - $55.64 $389,829 - $448,792
-8,066 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $46,662 - $57,109
1,050 Added 14.97%
8,066 $425,000
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $10,386 - $13,131
275 Added 4.08%
7,016 $326,000
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $230,137 - $272,673
6,741
6,741 $273,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.